The MM+M Podcast is Medical Marketing + Media’s show about healthcare marketing writ large. Each week, hosts Marc Iskowitz and Larry Dobrow — senior editors at the publication — interview the executives commercializing brands, the agencies supporting launches, and other fascinating guests from in and around the industries of pharma, biotech, med-tech ad-tech and health media.
Currax Pharmaceuticals CEO says the GLP-1 conversation isn’t one-size-fits-all
Currax Pharmaceuticals CEO George Hampton talks about the ascendance of GLP-1 drugs and how weight loss drugs are changing the obesity narrative.
4/20 focus: Why cannabis may be close to shedding its outlaw past
David Traylor of investment bank Golden Eagle Partners discusses the state of cannabis regulation. Plus, our Policy and Trends segments.
How Perrigo’s OTC birth control Opill partnered with the WNBA
Leila Bahbah, Perrigo U.S. Women’s Health Brand Lead, talks about how birth control medication Opill partnered with the WNBA.
Can NewYork-Presbyterian become a lifestyle brand?
NewYork-Presbyterian’s Devika Mathrani explains how the hospital system is rethinking its marketing to become more like a lifestyle brand.
Former NBA All Star Jamal Mashburn helms Exact Sciences’ colon cancer push
Former NBA All Star and Kentucky Wildcats legend Jamal Mashburn discusses his participation in Exact Sciences’ Box Out Colon Cancer campaign.
MM+M Transform 2024 preview: Northwell’s Ramon Soto and Lilly’s Derek Asay
On the eve of the 2024 MM+M Transform conference, Northwell Health’s Ramon Soto and Eli Lilly’s Derek Asay offer an advanced look at topics to be discussed at their sessions.
When a doctor turns digital influencer, part 2
Allergist turned digital health influencer Dr. Tania Elliott talks more about the ethical conundrums that can arise when medical influencers work with industry.
When a doctor turns digital influencer
Allergist Dr. Tania Elliott talks about her decision to become a full-time digital health influencer.
Brukinsa approval raises BeiGene’s hematology profile
BeiGene’s chief medical officer for hematology, Dr. Mehrdad Mobasher, discusses BTK inhibitor Brukinsa’s latest lymphoma approval from the FDA.
Allegra launches a GPS for clean-air routes at SXSW
Jordana Barish, senior director of Sanofi’s allergy portfolio, discusses the recent launch of the Allegra Airways tool at South by Southwest. Plus, policy updates and our Trends segment.
Why Xeomin is courting Demi Lovato’s fanbase
Merz Aesthetics’ Roberto Casas Rudbeck, VP of U.S. marketing aesthetics, explains why Xeomin chose Demi Lovato as its latest brand partner, plus policy updates and our Trends segment.
Will generative AI eliminate humans from pharma ads?
Lecia Bushak speaks with Lisa Leonard, a pharma voiceover actor, as well as Jim Kennelly, the owner of Lotas Productions, about the existential questions facing the life sciences and medical marketing industries as gen AI sets a practical foothold in the zeitgeist.
Me and My Heart: Raising awareness
Bill Fitzpatrick and Jack O’Brien reflect on their respective heart ailments and hear cardiovascular experts’ thoughts about the future of patient care.
Dermavant’s Todd Zavodnick is moving derm into the digital world
Immuno-dermatology needs to move to the digital era, Dermavant CEO Todd Zavodnick tells Jack O’Brien. Plus, policy updates and our Trends segment.
Me and My Heart: How do I live with this?
Post-hospital discharge, Bill Fitzpatrick adjusts to living with heart disease as he resumes working and trying to maintain a normal life.
MM+M 40 Under 40 2024 preview: From watching the sky to behavioral sci
MM+M 40 Under 40 honoree Jazmin Correa recounts her journey from typhoon forecaster in the Peace Corps to CX director at Merck.
Me and My Heart: I have what now?
Bill Fitzpatrick recalls the frantic hospital scene when doctors and nurses inserted a stent into his artery and stabilized him.
Sanofi’s AI-assisted pipeline strategy, unpacked by R&D lead
Sanofi’s global head of R&D portfolio strategy, Helen Merianos, explains how AI is helping make better pipeline decisions, plus policy updates and our Trends segment.
Me and My Heart: What the hell was that?
Bill Fitzpatrick is a 42-year-old married father of three and award-winning podcast producer. However, following a series of cardiac episodes that escalate in severity, he is diagnosed with a 90% blockage in his artery, becoming one of the millions of Americans living with heart disease.
Elanco’s Jeff Simmons talks launch planning
Elanco president/CEO Jeff Simmons says the animal health firm will ramp up advertising as it enters a “historic” launch phase, plus our policy and Trends segments.
